Stay updated on DARA/ATRA Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.

Latest updates to the DARA/ATRA Combo in Myeloma: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedClinicalTrials.gov’s study details page has updated its displayed revision/version from **v3.5.2** to **v3.5.3**, reflecting a non-content site release update.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0 and removed related topics: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check44 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check58 days agoChange Detected- Revision updated to v3.4.3. - Removed references to 'Multiple myeloma', related topics including MedlinePlus Genetics, and the 'Revision: v3.4.2' record.SummaryDifference0.2%

- Check86 days agoChange DetectedFooter now shows Revision: v3.4.2. The previous government funding/operating-status notice (Revision: v3.4.1) has been removed.SummaryDifference0.4%

Stay in the know with updates to DARA/ATRA Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.